Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
16 January 2015
Header
Header image
Highlight of the week

News

EFPIA and Innovative Medicines Initiative Announce New Ebola+ Projects to Further Collaborative Efforts Against Ebola
16 January 2015

(16 January 2015 – Brussels): EFPIA, the European Federation of Pharmaceutical Industries and Associations, and the Innovative Medicines Initiative are pleased to announce the newest [...] Read more

News

News

EFPIA launches new Ebola+ webpage
16 January 2015

EFPIA has launched a new informational page about Ebola and the Innovative Medicines Initiative’s Ebola+ programme. Visit the page here: http://imi.efpia.eu/ebola-programme  Read more

News

EFPIA Welcomes New US IOM Clinical Trial Data Sharing report
16 January 2015

EFPIA welcomes the launch of a new report from the US Institute of Medicine that makes recommendations for the responsible sharing of clinical trial data.  Richard [...] Read more

From our blog

From our blog

Time to reopen discussion on a more collaborative ethics committee assessment – perhaps cross-border?
15 January 2015 by Fabienne Zeegers Nick Sykes Richard Bergström Seth Cunningham Sue Forda

As predictable assessment timelines are crucial to ensure that Europe remains a competitive location for clinical research, it is important that the timelines set out by the legislation are respected by both the sponsor and Member States (MS).

Read more

Events calendar

Events Calendar

Going Live: Implementation of the Disclosure Code
On 29/01/2015 (Rotterdam)

On January 29th, Pharmadiscolsure.eu, the multi-stakeholder initiative supported by EFPIA, held a roundtable highlighting the implementation of EFPIA’s Responsible Transparency initiative. Hosted in Rotterdam by EFPIA’s Dutch association NEFARMA, the roundtable was part of a public information campaign launched to boost pharmaceutical industry preparedness in complying to new disclosure rules for certain financial and other transfers of value with healthcare professionals and organisations.

Discussion topics at the event included the successful multi-stakeholder implementation of transparency processes in the Netherlands, as well as the steps to implementation being undertaken in Poland and Germany.

The detailed event report will be released in the course of next week.

Read more

What we are reading

What we are reading

‘I can haz genomes’: cats claw their way into genetics
15 January 2015 (Nature)

Canine dominance bows to tabby chic as cat sequencing takes off.

Read more

What we are reading

Sharing Clinical Trial Data, Maximizing Benefits, Minimizing Risks
16 January 2015 (Institute of Medicine of the National Academies)

Independent report points the way forward for the responsible sharing of clinical trial data

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail